Skip to main content
Figure 2 | Veterinary Research

Figure 2

From: Memory T cell proliferative responses and IFN-γ productivity sustain long-lasting efficacy of a Cap-based PCV2 vaccine upon PCV2 natural infection and associated disease

Figure 2

Total resting PBMC and lymphoblasts upon in vitro stimulation after Cap protein PCV2 vaccination. Cell levels of resting and activated PBMC in PCV2-vaccinated (PCV2-vac) and control (C) pigs upon 48-h PCV2b (A, B) and PCV2b + PHA (C, D) in vitro stimulation during the post-vaccination (PV) period. Values are normalized to the corresponding medium (PCV2 stimulation) and PHA-alone (PCV2 + PHA stimulation) control samples, respectively. PCV2-vac pigs were vaccinated at 3 weeks of age using a PCV2a Cap protein-based subunit vaccine. (*): statistically significant difference between groups (p < 0.05).

Back to article page